A large-scale international study led by Professor Ole Andreassen in collaboration with an international consortium, offers new insights into understanding Alzheimer's disease and developing future treatments. The research, published in Nature, sheds clearer light on the role of immune cells within the brain, as well as several specific neuronal cell types.
A new study from the Norwegian Mother, Father and Child Cohort Study (MoBa) shows that parents’ genetics may be highly significant in understanding the effects of children’s own genes on traits such as height, academic achievement and mental health. The findings may have implications for how genetic studies are interpreted in future research.
Sara Stinson has received an award from Novo Nordisk for her research on biomarkers that may be important for children’s cardiometabolic health.
Through a groundbreaking collaboration, the University of Oslo (UiO) and the National Institute of Mental Health and Neuro Sciences (NIMHANS) in India will investigate cultural and biological causes of psychiatric conditions.
A new project at the University of Oslo (UiO) will investigate how our health in our 40s–60s affects the risk of dementia later in life. The MetaBrain project is funded by the Novo Nordisk Foundation.
Professor Srdjan Djurovic aims to identify early blood-based biomarkers that can predict who is at increased risk of developing Alzheimer’s disease. The goal is to intervene before the brain sustains irreversible damage, and ultimately to prevent the disease from developing at all.
A new study based on data from nearly one million individuals has unveiled that certain genetic variants could increase the risk for both psychiatric and neurological disorders. The findings may have implications for how we understand and treat brain diseases.
Andreassen receives the Colvin Prize for Outstanding Achievement in Mood Disorders Research for his groundbreaking research on bipolar disorder. "The award is a great recognition of our research environment, as many have contributed to the results we have achieved," the professor says.
Kevin O'Connell has been honored with the prestigious award for his work on understanding the factors contributing to the development of psychiatric disorders. His research stands out for its exceptional originality and high-level scientific activity on an international scale.
Shahram Bahrami and his colleagues have been granted NOK 12 million for Alzheimers’s research from the Research Council of Norway’s FRIPRO program Research Project for Experienced Scientists.
Postdoctoral researcher Dennis van der Meer and his colleagues are awarded 8 million NOK from the Research Council of Norway’s FRIPRO program Research Project for Young Talents.
New research from NORMENT finds that people with schizophrenia have a genetic propensity to smoking and a reduced genetic risk of obesity. The study highlight the importance of including lifestyle interventions in treatment for schizophrenia.
A new study indicates that some individuals are more prone to both using cannabis and developing mental disorders, such as schizophrenia and bipolar disorder, than others.
